Will the PCOS name change help young women get treatment?
About this episode
The episode discusses the reclassification of PCOS to PMOS and its implications for treatment and awareness among young women.
PCOS is one of the most common hormonal disorders affecting women globally; affecting roughly 13% of women who have a menstrual cycle. The World Health Organization has estimated that up 70% of women with PCOS worldwide do not know they have this condition. Symptoms can include irregular periods, fertility issues, weight gain, acne, excess hair growth and insulin resistance. There is no cure. And now Polycystic ovary syndrome (PCOS) is officially being reclassified as polyendocrine metabolic ovarian syndrome (PMOS). The new name reflects growing recognition that the condition involves much more than ovarian cysts alone. It’s actually a complex endocrine condition (to do with hormones) which affects the whole body. Experts hope that the name change will lead to a better focus on treating and reversing some of symptoms. Global health reporter Dorcas Wangira in Kenya explains what we know about the condition. And we hear from Professor Helena Teede, from Monash Univerity in Australia, who led the name-changing initiative. Jenef Ngombo, 25 from the UK and Chelle Robotham, in Florida USA, share their experiences of PMOS/PCOS and tell us what they think about the name change…
More episodes of What in the World
- Why does President Trump want Iran’s Kharg Island?
- Why is Russia cutting the internet and blocking apps?
- Can AI help us save endangered languages?
- Google wants to release millions of mosquitoes in the US
- Protests against illegal migrants in South Africa: What’s going on?
- Job hugging: Why nobody wants to quit their job
Explore listener stats, chart rankings, contacts and more on the What in the World podcast page.